DK0519353T3 - Indolizinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat, der indeholder derivaterne - Google Patents

Indolizinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat, der indeholder derivaterne

Info

Publication number
DK0519353T3
DK0519353T3 DK92109968T DK92109968T DK0519353T3 DK 0519353 T3 DK0519353 T3 DK 0519353T3 DK 92109968 T DK92109968 T DK 92109968T DK 92109968 T DK92109968 T DK 92109968T DK 0519353 T3 DK0519353 T3 DK 0519353T3
Authority
DK
Denmark
Prior art keywords
alkyl
derivatives
chem
hydrogen
processes
Prior art date
Application number
DK92109968T
Other languages
Danish (da)
English (en)
Inventor
Akio Kuroda
Hirokazu Tanaka
Satoshi Okada
Kozo Sawada
Shinya Watanabe
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919113027A external-priority patent/GB9113027D0/en
Priority claimed from GB919120764A external-priority patent/GB9120764D0/en
Priority claimed from GB919124345A external-priority patent/GB9124345D0/en
Priority claimed from GB929203809A external-priority patent/GB9203809D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0519353T3 publication Critical patent/DK0519353T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
DK92109968T 1991-06-17 1992-06-13 Indolizinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat, der indeholder derivaterne DK0519353T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919113027A GB9113027D0 (en) 1991-06-17 1991-06-17 Indolizine derivatives
GB919120764A GB9120764D0 (en) 1991-09-30 1991-09-30 Heterocyclic derivatives
GB919124345A GB9124345D0 (en) 1991-11-15 1991-11-15 Heterocyclic derivatives
GB929203809A GB9203809D0 (en) 1992-02-21 1992-02-21 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
DK0519353T3 true DK0519353T3 (da) 2000-09-18

Family

ID=27450702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92109968T DK0519353T3 (da) 1991-06-17 1992-06-13 Indolizinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat, der indeholder derivaterne

Country Status (17)

Country Link
US (1) US5334716A (zh)
EP (1) EP0519353B1 (zh)
JP (1) JP2663794B2 (zh)
KR (1) KR100244879B1 (zh)
CN (1) CN1042226C (zh)
AT (1) ATE195521T1 (zh)
AU (1) AU656197B2 (zh)
CA (1) CA2071375C (zh)
DE (1) DE69231350T2 (zh)
DK (1) DK0519353T3 (zh)
ES (1) ES2149160T3 (zh)
GR (1) GR3034429T3 (zh)
HU (2) HUT61544A (zh)
IE (1) IE921805A1 (zh)
MX (1) MX9202901A (zh)
PT (1) PT519353E (zh)
TW (1) TW203050B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318790D0 (en) * 1993-09-10 1993-10-27 Fujisawa Pharmaceutical Co Heterocyclic derivatives
US6214876B1 (en) 1994-07-21 2001-04-10 Eli Lilly And Company Indene-1-acetamide sPLA2 inhibitors
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
WO2003020311A1 (fr) * 2001-08-28 2003-03-13 Fujisawa Pharmaceutical Co., Ltd. Remedes contre les maladies de la peau
CN1678314A (zh) * 2002-08-27 2005-10-05 默克专利有限公司 作为raf－激酶抑制剂的甘氨酸酰胺衍生物
EP1543875A1 (en) * 2003-12-04 2005-06-22 Boehringer Ingelheim Pharma GmbH & Co. KG Novel metathesis ruthenium catalyst
FR2893616B1 (fr) * 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
CN101486710B (zh) * 2009-02-11 2011-04-06 中国科学院上海有机化学研究所 一种合成3-卤代中氮茚类化合物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268424A (en) * 1969-10-04 1972-03-29 Beecham Group Ltd Indolizine derivatives
US3806513A (en) * 1969-10-04 1974-04-23 Beecham Group Ltd Alpha-substituted indolizine propionic acid and its salts
US4205074A (en) * 1977-05-16 1980-05-27 Hokuriku Pharmaceutical Co., Ltd. Anti-spasmodic substituted quinolizidine and indolizidine compounds
DE3851262T2 (de) * 1987-06-04 1995-02-02 Ono Pharmaceutical Co Benzoylaminophenoxybuttersäure-Derivate.
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof

Also Published As

Publication number Publication date
CN1067893A (zh) 1993-01-13
EP0519353A3 (en) 1993-04-14
GR3034429T3 (en) 2000-12-29
ATE195521T1 (de) 2000-09-15
HU211621A9 (en) 1995-12-28
DE69231350D1 (de) 2000-09-21
KR930000513A (ko) 1993-01-15
EP0519353A2 (en) 1992-12-23
IE921805A1 (en) 1992-12-30
MX9202901A (es) 1993-05-01
CA2071375C (en) 2003-02-11
HUT61544A (en) 1993-01-28
AU656197B2 (en) 1995-01-27
CN1042226C (zh) 1999-02-24
CA2071375A1 (en) 1992-12-18
AU1827092A (en) 1992-12-24
HU9201993D0 (en) 1992-09-28
JP2663794B2 (ja) 1997-10-15
KR100244879B1 (ko) 2000-03-02
ES2149160T3 (es) 2000-11-01
EP0519353B1 (en) 2000-08-16
TW203050B (zh) 1993-04-01
PT519353E (pt) 2000-12-29
DE69231350T2 (de) 2001-01-04
JPH05178856A (ja) 1993-07-20
US5334716A (en) 1994-08-02

Similar Documents

Publication Publication Date Title
DK0443132T3 (da) Peptider med tachykininantagonistaktivitet, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende samme
DK0467248T3 (da) Pyrazolopyridinforbindelse og fremgangsmåder til fremstilling heraf
FI890689A (fi) 3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
DK0458207T3 (zh)
DK0519353T3 (da) Indolizinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat, der indeholder derivaterne
IL90424A0 (en) Cephem derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DK702788A (da) Thioformamidderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
EP0420086A3 (en) Pyrimidoindole derivatives and processes for preparation thereof